| Literature DB >> 32423483 |
Ziyue Yang1, Cuihong Qin1, Shuguang Zhang1, Shaohua Liu1, Tongwen Sun2.
Abstract
Entities:
Mesh:
Year: 2020 PMID: 32423483 PMCID: PMC7236112 DOI: 10.1186/s13054-020-02959-7
Source DB: PubMed Journal: Crit Care ISSN: 1364-8535 Impact factor: 9.097
Patient’s characteristics
| Characteristic | All sepsis patients# | SAE* | Non-SAE* | SAE recovery* |
|---|---|---|---|---|
| Gender (male, | 54 (60.0%) | 30 (58.8%) | 41 (57.7%) | 12 (60%) |
| Age (years, median [IQR]) | 45 [32, 69] | 49 [32, 70] | 45 [32, 67] | 58 [38, 76] |
| APACHE II score (median [IQR]) | 14 [9, 17] | 22 [19.5, 28.5] | 12 [9, 15] | 12.5 [10, 15] |
| APACHE II score without GCS | 14 [9.25, 18.75] | 19 [15, 23] | 12 [9, 15] | 12.5 [10, 15] |
| SOFA score (median [IQR]) | 8 [5, 12] | 13 [12, 17] | 6 [5, 9] | 5 [3, 6] |
| GCS score (median [IQR]) | 15 [15, 15] | 12 [6, 14] | 15 | 15 |
| Serum lactic acid (median [IQR]) | 2.7 [1.9, 5.1] | 6.7 [2.45, 15] | 2.1 [1.45, 2.75] | 2.4 [2.1, 4.375] |
| PCT (median [IQR]) | 3.5 [2.1, 8] | 17 [7.5, 36] | 2.4 [1.8, 4.5] | 2.4 [1.45, 3.3] |
| Albumin (median [IQR]) | 30.1 [27.1, 32.1] | 28.9 [25.5, 31.05] | 30.5 [27.6, 32.2] | 34.75 [29.7, 36] |
| MV time (hours, median [IQR]) | 33.5 [0, 67] | 63 [50, 98.5] | 5 [0, 52] | 63 [33, 91.5] |
| In-hospital days (median [IQR]) | 16 [10, 20] | 15 [9.5, 22] | 17 [11, 22] | 16 [14.25, 24.25] |
| In-ICU days (median [IQR]) | 12.5 [9, 18] | 12 [9, 20] | 15 [9, 20] | 14.5 [10.75, 18.5] |
| 28-day mortality ( | 45 (50%) | 31 (60.7%) | 33 (46.4%) | 0 |
| ONSD (mm) | 5.4 [5, 5.7] | 5.9 [5.6, 6.25] | 5.1 [4.75, 5.4] | 5.35 [5.075, 5.5] |
Data are median [IQR] or n (%)
Non-SAE sepsis patients with a clear head, without SAE; SAE recovery SAE patients who received effective therapy and whose GCS score recovered to 15 points; APACHE II Acute Physiology and Chronic Health Evaluation II; SOFA Sequential Organ Failure Assessment; GCS Glasgow Coma Scale; PCT procalcitonin; IQR interquartile range; MV mechanical ventilation; ICU intensive care unit; ONSD optic nerve sheath diameter
#Patient data collected in the first 24 h after admission
*Patient data collected in the first 24 h after the diagnosis of SAE or SAE recovery
Fig. 1a Ultrasonographic images of the optic nerve sheath in a patient with non-sepsis-associated encephalopathy. b Ultrasonographic images of the optic nerve sheath in a patient with sepsis-associated encephalopathy (SAE) (ONSD, optic nerve sheath diameter). c The receiver operating characteristic (ROC) curve for optic nerve sheath diameter (ONSD) to diagnose septic encephalopathy. d The ROC curve for ONSD to predict 28-day survival in patients with sepsis-associated encephalopathy (AUC, area under the curve). e Comparison of the optic nerve sheath diameter among the three patient groups (SAE, sepsis-associated encephalopathy)